Home > Cashflow Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MEDICAMEN BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹-8.16 Cr₹-6.74 Cr₹-6.29 Cr₹4.11 Cr₹13 Cr

What is the latest Cash Flow from Operating Activities ratio of MEDICAMEN BIOTECH ?

The latest Cash Flow from Operating Activities ratio of MEDICAMEN BIOTECH is ₹-8.16 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹-8.16 Cr
Mar2024₹-6.74 Cr
Mar2023₹-6.29 Cr
Mar2022₹4.11 Cr
Mar2021₹13 Cr

How is Cash Flow from Operating Activities of MEDICAMEN BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹-8.16 Cr
Negative
Mar2024 ₹-6.74 Cr
Negative
Mar2023 ₹-6.29 Cr
Negative
Mar2022 ₹4.11 Cr
-67.83
Mar2021 ₹13 Cr -

Compare Cash Flow from Operating Activities of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹502.0 Cr 5.9% -2.5% -21.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,559.0 Cr 7.1% -1.5% -6.2% Stock Analytics
DIVIS LABORATORIES ₹164,827.0 Cr 2.8% -2.8% 6% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,942.0 Cr 3.1% 4.2% 18.8% Stock Analytics
CIPLA ₹106,825.0 Cr 0.2% -12.5% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,077.0 Cr 2.2% -1.6% 0% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

5.9%

-2.5%

-21.1%

SENSEX

1.7%

-1.7%

10.3%


You may also like the below Video Courses